Trial investigating potential treatment for fatigue relief in people with long COVID reports results

Published on April 14, 2023

Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue.

The study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given a placebo.
Continue reading on website
Other news

R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana

April 13, 2023
The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Ghana by the country’s Food and Drugs Authority.

Opening doors: our EMBA scholars share their experiences

April 14, 2023
From charity and healthcare to women in leadership, Cambridge Judge Business School (CJBS) awards a number of scholarships to candidates on its Executive MBA programme. We spoke to current and past recipients to find out more about how the support has helped them pursue their goals and advance their careers. EMBA alumna Emma Kent with her children on graduation day Diversity is at the heart of